Separate opportunities in antiseptic solutions and sterile medical products. A specialist operating partner and a defined hospital or distributor contract can support one initial product platform.
Proposed scale: 49,500 tonnes of solutions and 450 million consumable items
Preliminary capital reference: 164.30 USD million
The amount refers to the full proposed scope. The first-phase budget and funding structure will be agreed after technical quotations and scope validation.
Project basis: This is a proposed investment concept. Capacity, ownership and operating rights, permits and transaction terms require project-specific confirmation.
Confirm product classification, licences, sterile validation and tender prices; cost each process and product separately.
Project equity, a technical or operating partnership, equipment finance or an offtake arrangement may be considered. The structure and investable rights will be agreed with the authorised project owner.